BRIEF published on 03/16/2026 at 10:45, 1 month 23 days ago Zentiva Releases 2025 Sustainability Report Highlighting Environmental and Social Progress Renewable Energy Public Health Sustainability Report Environmental Responsibility Medicines Accessibility
BRIEF published on 03/16/2026 at 10:45, 1 month 23 days ago Zentiva publie son rapport de développement durable 2025, mettant en lumière ses progrès environnementaux et sociaux. Énergie Renouvelable Responsabilité Environnementale Santé Publique Rapport Sur Le Développement Durable Accessibilité Des Médicaments
PRESS RELEASE published on 03/16/2026 at 10:40, 1 month 23 days ago Zentiva publishes 2025 Sustainability Report reinforcing commitment to people, partners and the planet. Zentiva publishes 2025 Sustainability Report demonstrating commitment to public health impact, environmental stewardship, and responsible business practices Public Health Sustainability Report Environmental Stewardship Zentiva Business Practices
BRIEF published on 02/23/2026 at 12:20, 2 months 13 days ago Zentiva Calls for Urgent Reevaluation of Waste Water Directive EU Regulation Generic Medicines Zentiva UWWTD Medicine Supply
BRIEF published on 02/23/2026 at 12:20, 2 months 13 days ago Zentiva appelle à une réévaluation urgente de la directive sur les eaux usées Médicaments Génériques Règlement De L'UE Zentiva UWWTD Fournitures Médicales
PRESS RELEASE published on 02/23/2026 at 12:15, 2 months 13 days ago Zentiva Demands EU-Level Stop-the-Clock on the UWWTD to Protect Medicine Availability Zentiva demands EU-level stop-the-clock on UWWTD to protect medicine availability, calling for a pause, new studies, and a relaunch of the directive. CEO emphasizes need for stakeholder cooperation Zentiva UWWTD EU-level Medicine Availability Directive
BRIEF published on 12/01/2025 at 10:10, 5 months 7 days ago Zentiva Enters Biologics Market with EU Biosimilar Launch Biosimilar Biologics Healthcare Sustainability Zentiva EMA Approval
BRIEF published on 12/01/2025 at 10:10, 5 months 7 days ago Zentiva fait son entrée sur le marché des produits biologiques avec le lancement d'un biosimilaire en Europe. Produits Biologiques Biosimilaire Durabilité Des Soins De Santé Zentiva Approbation De L'EMA
PRESS RELEASE published on 12/01/2025 at 10:05, 5 months 7 days ago Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar Zentiva expands into biologics by launching its first biosimilar across Europe, aiming to enhance patient access to high-quality biological medicines Biosimilar Biologics Zentiva Patient Access EU-wide Launch
BRIEF published on 11/28/2025 at 16:15, 5 months 10 days ago Zentiva Honored with 2025 ESG Transparency Award Renewable Energy Sustainability Transparency Corporate Responsibility ESG Reporting
Published on 05/09/2026 at 00:00, 1 hour 22 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 2 hours 22 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 2 hours 52 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 2 hours 52 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 4 hours 44 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 6 hours 10 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 6 hours 20 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
